Lactobacillus plantarum YS2 (yak yogurt Lactobacillus) exhibited an activity to attenuate activated carbon-induced constipation in male Kunming mice

Qian, Yu; Li, Guijie; Yi, Ruokun; Park, Kun-Young; Song, Jia‐Le

doi:10.3168/jds.2018-15206

Cited by 34 publications

(24 citation statements)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Neurotransmitter also plays an important role in gastrointestinal hormones [28]. A couple of neurotransmitters have been identified to be associated with the motor activity of the gastrointestinal tract, such as Ach, NO, SP, and VIP, which play important roles in the regulation of gastrointestinal motility [14,24,29]. Among them, Ach and SP are excitatory neurotransmitters that promote bowel motility and speed defecation, while NO and VIP are inhibitory neurotransmitters that relax the gastrointestinal tract and inhibit bowel movement [3,30].…”

Section: Discussionmentioning

confidence: 99%

The Constipation-Relieving Property of d-Tagatose by Modulating the Composition of Gut Microbiota

Liang

Wen

Wang

et al. 2019

IJMS

View full text Add to dashboard Cite

d-tagatose, a monosaccharide as well as a dietary supplement, has been reported as having a wide range of applicability in the food industry, however, the prebiotic activity, anticonstipation effects, and related mechanisms are still unclear. In this study, using the loperamide-induced constipation Kunming mice as the animal model, the effects of d-tagatose for the prevention of constipation were evaluated by gastrointestinal transit experiment and defecation experiment. Furthermore, the underlying mechanism was clarified by evaluating the change of the biochemical indicators and analyzing 16S rRNA amplicon of gut microbiota among the different mice groups. The results showed that the gastrointestinal transit rate, fecal number, and weight in six hours were significantly enhanced after the administration of d-tagatose. In addition, d-tagatose significantly increased the serum levels of acetylcholine (Ach) and substance P (SP), whereas the serum levels of nitric oxide (NO) were significantly decreased. Moreover, the 16S rRNA sequencing analysis revealed that the changes in the gut microbiota caused by constipation were restored by d-tagatose treatment. In conclusion, this study indicated that the administration of d-tagatose as a dietary supplement can effectively prevent and relieve constipation in Kunming mice, and it is a promising prebiotic candidate with constipation-relieving properties.

show abstract

Section: Discussionmentioning

confidence: 99%

The Constipation-Relieving Property of d-Tagatose by Modulating the Composition of Gut Microbiota

Liang

Wen

Wang

et al. 2019

IJMS

View full text Add to dashboard Cite

show abstract

“…The PCR was performed in an automatic thermocycler (QuantStudio 6 Flex PCR, Life Technologies) with the following parameters: 95°C for 60 s; 40 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 50 s; 75°C for 10 min. GAPDH was selected as an internal reference, and the relative expression of cluster of differentiation 117 (c-Kit), stem cell factor (SCF) glial cell-derived neurotrophic factor (GDNF), inducible nitric oxide synthase (iNOS), transient receptor potential vanilloid-1 (TRPV1) and cyclooxygenase-2 (COX-2) mRNA was calculated using the 2 −ΔΔCt formula (Zhao et al, 2019). Note: Values presented are the mean ± standard deviation (n = 10/group).…”

Section: Total Rna Extraction and Quantitative Pcr Assaymentioning

confidence: 99%

“…Constipation is a clinical manifestation of digestive system disorders and is characterized by the formation of hard feces that are difficult to excrete. The prevalence of constipation ranges from 2% to 30%, especially in children and geriatric populations (Chen, Chao, & Pan, 2020;Zhao et al, 2019). Constipation can be divided into primary and secondary constipation, with primary constipation including three types (i.e., normal-transit constipation, slow-transit constipation, and defecatory disorders) (Lembo & Camilleri, 2003).…”

Section: Introductionmentioning

confidence: 99%

“…As a natural bioactive constituent, it has been proven that geniposide is a curative substance for diseases of the digestive system (Qian, Suo, Yi, Li, & Zhao, 2017). Lactobacillus strains also can effectively alleviate constipation (Chen et al, 2020;Zhao et al, 2019). Therefore, this study evaluated the potential synergic effect of the combination of Lactobacillus plantarum KSFY06 (LP-KSFY06) and geniposide.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Lactobacillus plantarum KSFY06 and geniposide counteract montmorillonite‐induced constipation in Kunming mice

Gan

Liang

Diao

et al. 2020

Food Science & Nutrition

Self Cite

View full text Add to dashboard Cite

Constipation is a common clinical manifestation of digestive system disorders and occurs worldwide. This study investigated the ability of Lactobacillus plantarum KSFY06 (LP‐KSFY06) to promote the action of geniposide in preventing montmorillonite‐induced constipation in Kunming mice, with the aim of providing a successful solution. The effects of LP‐KSFY06 and geniposide on constipation were measured, and the results showed that the protective effect of geniposide on constipation was enhanced by LP‐KSFY06 and that the combination resulted in increased weight, moisture content, and particle number of feces. The first black stool defecation time was decreased from 182 min to 87 min, which clearly indicates that defecating difficulty was alleviated in constipated mice. The synergic intervention of LP‐KSFY06 and geniposide (LP + G) assisted in maintaining the body weight of constipated mice. The LP + G intervention significantly increased serum levels of motilin (MTL, 167.8 pg/ml), acetylcholinesterase (AChE, 45.3 pg/ml), substance P (SP, 61.0 pg/ml), vasoactive intestinal peptide (VIP, 70.5 pg/ml), endothelin‐1 (ET‐1, 16.1 pg/ml), and gastrin (73.0 pg/ml) and remarkably decreased somatostatin (SS, 35.2 pg/ml) when compared to those indexes in the LP‐KSFY06 group and geniposide group. The LP + G treatment also significantly increased the mRNA expression of cluster of differentiation 117 (c‐Kit), stem cell factor (SCF), glial cell‐derived neurotrophic factor (GDNF), and remarkably downregulated the expression of inducible nitric oxide synthase (iNOS), transient receptor potential vanilloid‐1 (TRPV1), and cyclooxygenase‐2 (COX‐2). The experimental results showed that the combination treatment has the strongest prevention effect against constipation, and LP‐KSFY06 promotes the ability of geniposide to prevent constipation. Therefore, LP‐KSFY06 is a potential probiotic strain with the capacity to prevent montmorillonite‐induced constipation.

show abstract

“…Mice in the LC‐YBJ02‐L, LC‐YBJ02‐M, and LC‐YBJ02‐H groups were given 0.2 mL different concentrations of bacterial suspension at 16:00 a day by gavage. The concentrations were 10 8 colony forming units (CFU)/kg, 10 9 CFU/kg, and 10 10 CFU/kg LC‐YBJ02 (Zhao et al., ), and the test lasted for 6 weeks. During the experiment, the weights of the mice prior to gavage were recorded.…”

Section: Methodsmentioning

confidence: 99%

Effects of Lactobacillus Casei YBJ02 on Lipid Metabolism in Hyperlipidemic Mice

Qian

Wang

et al. 2019

Journal of Food Science

Self Cite

View full text Add to dashboard Cite

Traditionally fermented yak yogurt as a Tibetan dairy product is high not only in nutrients but also in probiotics. A probiotic strain with a potential lipid reducing effect was isolated from yak yogurt. An animal model for hyperlipidemia was evaluated using the blood index and expression levels of lipid metabolism-related proteins in mice to determine the effect of Lactobacillus casei YBJ02 (LC-YBJ02) on lipid metabolism in hyperlipidemic mice and the underlying mechanism. LC-YBJ02 at different concentrations exhibited certain inhibitory effects on the increase in blood lipid in mice. Particularly, high concentrations of LC-YBJ02 can reduce the cholesterol, triglycerides, and low-density lipoprotein content; however, no significant effect on the high-density lipoprotein of the body has been reported. LC-YBJ02 can effectively increase the reduction in cholesterol level by fecal excretion. In this study, the gene-affecting mouse obesity was determined using experimental results in mice. The expression levels of peroxisome proliferator-activated receptor γ (PPARγ ), CCAAT enhancer binding protein alpha (CEBP)/α, sterol regulatory element binding protein (SREBP)-1c, and FAS could improve because of the high-fat diet in kidney fat. Bacteria at different concentrations could also decrease these expression levels. Specifically, the high concentration of LC-YBJ02 could suppress the expression of PPARγ , CEBP/α, and SREBP-1c; however, the expression of FAS was not significantly inhibited. PPARγ and FAS expression levels in the liver were low, but no significant difference was indicated. CEBP/α and SREBP-1c expression in mouse liver was further detected by Western blot analysis; CEBP/α was considerably low and could not be detected. On the basis of these results, LC-YBJ02 could be used as probiotics through its lipid reduction effects.

show abstract

Lactobacillus plantarum YS2 (yak yogurt Lactobacillus) exhibited an activity to attenuate activated carbon-induced constipation in male Kunming mice

Cited by 34 publications

References 59 publications

The Constipation-Relieving Property of d-Tagatose by Modulating the Composition of Gut Microbiota

The Constipation-Relieving Property of d-Tagatose by Modulating the Composition of Gut Microbiota

Lactobacillus plantarum KSFY06 and geniposide counteract montmorillonite‐induced constipation in Kunming mice

Effects of Lactobacillus Casei YBJ02 on Lipid Metabolism in Hyperlipidemic Mice

Contact Info

Product

Resources

About